TWBM
台灣生醫材料股份有限公司
TWBM: Foamagen (foam artificial dura; medical device) — Company lists Taiwan sales; TFDA extended post-market safety surveillance. As of 2026-11-01.
Pipeline and products
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| Foamagen (foam artificial dura; medical device) | — | Company lists Taiwan sales; TFDA extended post-market safety surveillance | Artificial dura substitute | — | 2026-05-19 | Company disclosure |
| Thrombus aspiration pump system (medical device) | — | Company reports US FDA 510(k) clearance; clearance number and date unconfirmed | Interventional removal of cerebral stroke thrombi | — | — | Company disclosure |
| Early osteoarthritis tissue repair / regeneration product | — | — | Tissue repair research for early osteoarthritis | — | — | Company disclosure |
Key events
Related Drugnews articles
No related articles in this language.